Certified by Founder Lodge
Alveus Therapeutics Inc
United States - Philadelphia, Pennsylvania
START UP
1 Disclosed Funding Rounds $160,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, designed for sustained efficacy, improved tolerability,
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2026 | Series A | $160,000,000 |
Sanofi
Andera Partners
Omega Funds
Kurma Partners
New Rhein Healthcare Investors
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
